2. Search Result
Search Result
Results for "

Ro 22-7796

" in MedChemExpress (MCE) Product Catalog:

7

Inhibitors & Agonists

4

Isotope-Labeled Compounds

Targets Recommended:
Cat. No. Product Name Target Research Areas Chemical Structure
  • HY-106577
    Cibenzoline

    Cifenline; Ro 22-7796

    		 Potassium Channel Cardiovascular Disease Metabolic Disease
    Cibenzoline is a class Ia antiarrhythmic active molecule with low anticholinergic activity. Cibenzoline is a KATP channel inhibitor, acting through the pore forming subunit Kir6.2, with an IC50 of 22.2 μM. Cibenzoline inhibits IKr and IKs currents with IC50 values of 8.8 μM and 12.3 μM, respectively. Cibenzoline is used in the study of cardiac diseases. In addition, Cibenzoline can induce hypoglycemia .
    Cibenzoline
  • HY-115014
    Cibenzoline succinate

    Cifenline succinate; Ro 22-7796 succinate

    		 Potassium Channel Cardiovascular Disease Metabolic Disease
    Cibenzoline succinate (Cifenline succinate) is the succinate form of Cibenzoline (HY-106577). Cibenzoline succinate is an inhibitor for ATP-sensitive potassium (KATP) channel by affecting the pore-forming Kir6.2 subunit with IC50 of 22.2 µM. Cibenzoline succinate affects insulin secretion and exhibits antiarrhythmic and antidiabetic activities .
    Cibenzoline succinate
  • HY-106577S
    Cibenzoline-d4

    Cifenline-d4; Ro 22-7796-d4

    		 Isotope-Labeled Compounds Potassium Channel Cardiovascular Disease Metabolic Disease
    Cibenzoline-d4 (Cifenline-d4) is deuterium labeled Cibenzoline. Cibenzoline is a class Ia antiarrhythmic active molecule with low anticholinergic activity. Cibenzoline is a KATP channel inhibitor, acting through the pore forming subunit Kir6.2, with an IC50 of 22.2 μM. Cibenzoline inhibits IKr and IKs currents with IC50 values of 8.8 μM and 12.3 μM, respectively. Cibenzoline is used in the study of cardiac diseases. In addition, Cibenzoline can induce hypoglycemia .
    Cibenzoline-d4
  • HY-106577S1
    Cibenzoline-d5

    Cifenline-d5; Ro 22-7796-d5

    		 Isotope-Labeled Compounds Cardiovascular Disease Metabolic Disease
    Cibenzoline-d5 (Cifenline-d5) is deuterium labeled Cibenzoline. Cibenzoline is a class Ia antiarrhythmic active molecule with low anticholinergic activity. Cibenzoline is a KATP channel inhibitor, acting through the pore forming subunit Kir6.2, with an IC50 of 22.2 μM. Cibenzoline inhibits IKr and IKs currents with IC50 values of 8.8 μM and 12.3 μM, respectively. Cibenzoline is used in the study of cardiac diseases. In addition, Cibenzoline can induce hypoglycemia .
    Cibenzoline-d5
  • HY-106577A
    (-)-(S)-Cibenzoline

    Escibenzoline; (-)-(S)-Cifenline; (-)-(S)-Ro 22-7796

    		 Potassium Channel Metabolic Disease
    (-)-(S)-Cibenzoline (Escibenzoline), a S(+)-enantiomer of Cibenzoline, is an antiarrhythmic agent .
    (-)-(S)-Cibenzoline
  • HY-158187S
    R-(+)-Cibenzoline-d4

    R-(+)-Cifenline-d4; R-(+)-Ro 22-7796-d4

    		 Isotope-Labeled Compounds Others
    R-(+)-Cibenzoline-d4 (R-(+)-Cifenline-d4) is deuterium labeled R-(+)-Cibenzoline ((R-(+)-Cifenline) .
    R-(+)-Cibenzoline-d4
  • HY-106577AS
    (-)-(S)-Cibenzoline-d4

    Escibenzoline-d4; (-)-(S)-Cifenline-d4; (-)-(S)-Ro 22-7796-d4

    		 Isotope-Labeled Compounds Potassium Channel Metabolic Disease
    (-)-(S)-Cibenzoline-d4 (Escibenzoline-d4) is deuterium labeled (-)-(S)-Cibenzoline. (-)-(S)-Cibenzoline (Escibenzoline), a S(+)-enantiomer of Cibenzoline, is an antiarrhythmic agent .
    (-)-(S)-Cibenzoline-d4

Inquiry Online

Your information is safe with us. * Required Fields.

Salutation

  

Country or Region *

Applicant Name *

 

Organization Name *

Department *

     

Email Address *

 

Product Name *

Cat. No.

  

Requested quantity *

Phone Number *

     

Remarks

Inquiry Online

Inquiry Information

Product Name:
Cat. No.:
Quantity:
MCE Japan Authorized Agent: